Delaware-based Ashford Capital Management announced the acquisition of an additional 434,615 shares of Cellebrite (NASDAQ:CLBT) during the third quarter, increasing its investment by approximately $11.3 million. As of September 30, the fund’s total holdings in Cellebrite reached 1.7 million shares, valued at $31.5 million. This purchase elevated Cellebrite to 3.5% of Ashford’s reportable U.S. equity AUM, making it the fund’s fifth-largest holding. The filing was made public on Friday through the Securities and Exchange Commission.
